source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-27 17:32:00
| null |
ISS ACKNOWLEDGES ZIOPHARM'S OUTPERFORMANCE OF ITS PEER GROUP DURING CHAIRMAN SCOTT TARRIFF'S TENURE
|
ZIOPHARM COMMENTS ON INSTITUTIONAL SHAREHOLDER SERVICES' RECOMMENDATION TO REJECT WATERMILL'S ATTEMPT TO REMOVE HALF OF ZIOPHARM'S BOARD OF DIRECTORS
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-25 20:30:00
| null |
NEW YORK--(BUSINESS WIRE)--WATERMILL ASSET MANAGEMENT CORP. (TOGETHER WITH ITS AFFILIATES, “WATERMILL” OR “WE”), WHICH COLLECTIVELY WITH THE OTHER PARTICIPANTS IN ITS CONSENT SOLICITATION BENEFICIALLY OWNS APPROXIMATELY 3.3% OF THE OUTSTANDING SHARES OF ZIOPHARM ONCOLOGY, INC. (NASDAQ: ZIOP) (“ZIOPHARM” OR THE “COMPANY”), TODAY ANNOUNCED THAT INSTITUTIONAL SHAREHOLDER SERVICES INC. (“ISS”), A LEADING INDEPENDENT PROXY VOTING ADVISORY FIRM, RECOMMENDS SHAREHOLDERS VOTE FOR BOARDROOM CHANGE ON TH
|
ISS RECOMMENDS ZIOPHARM SHAREHOLDERS VOTE FOR CHANGE ON WATERMILL ASSET MANAGEMENT'S WHITE CONSENT CARD
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-24 09:00:00
| null |
NEW YORK--(BUSINESS WIRE)--WATERMILL ASSET MANAGEMENT CORP. (TOGETHER WITH ITS AFFILIATES, “WATERMILL” OR “WE”), WHICH COLLECTIVELY WITH THE OTHER PARTICIPANTS IN ITS CONSENT SOLICITATION BENEFICIALLY OWNS APPROXIMATELY 3.3% OF THE OUTSTANDING SHARES OF ZIOPHARM ONCOLOGY, INC. (NASDAQ: ZIOP) (“ZIOPHARM” OR THE “COMPANY”), TODAY RELEASED A NEW REBUTTAL PRESENTATION IN RESPONSE TO THE INCUMBENT BOARD OF DIRECTORS' (THE “BOARD”) RECENT ATTEMPT TO MISLEAD SHAREHOLDERS AND REWRITE HISTORY REGARDING
|
WATERMILL ASSET MANAGEMENT SETS THE RECORD STRAIGHT FOLLOWING ZIOPHARM'S APPARENT ATTEMPT TO MISLEAD SHAREHOLDERS AND REWRITE HISTORY
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-20 11:00:00
| null |
CO NTINUES TO EXECUTE ON STRATEGY TO ENSURE STRONG LONG-TERM OUTLOOK
|
ZIOPHARM RELEASES INVESTOR PRESENTATION HIGHLIGHTING EXECUTION OF STRATEGY AND SUBSTANTIAL BOARD REFRESHMENT TO ENHANCE SHAREHOLDER VALUE
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-19 09:30:00
| null |
NEW YORK--(BUSINESS WIRE)--WATERMILL ASSET MANAGEMENT CORP. (TOGETHER WITH ITS AFFILIATES, “WATERMILL” OR “WE”), WHICH COLLECTIVELY WITH THE OTHER PARTICIPANTS IN ITS CONSENT SOLICITATION BENEFICIALLY OWNS APPROXIMATELY 3.3% OF THE OUTSTANDING SHARES OF ZIOPHARM ONCOLOGY, INC. (NASDAQ: ZIOP) (“ZIOPHARM” OR THE “COMPANY”), TODAY RELEASED A 55-PAGE PRESENTATION THAT DETAILS THE CASE FOR URGENT CHANGE IN THE BOARDROOM AND SUMMARIZES ITS DIRECTOR CANDIDATES' VALUE-ENHANCING VISION. AS A REMINDER, W
|
WATERMILL ASSET MANAGEMENT RELEASES PRESENTATION DETAILING THE CASE FOR URGENT CHANGE ATOP ZIOPHARM ONCOLOGY
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-19 09:00:00
| null |
– FIRST DATA FROM ONGOING PHASE 2 STUDY OF CONTROLLED IL-12 IN COMBINATION WITH CEMIPLIMAB DEMONSTRATE PROMISING SAFETY PROFILE IN RGBM, AND A CONFIRMED PARTIAL RESPONSE –
|
ZIOPHARM ONCOLOGY PRESENTS ENCOURAGING CLINICAL DATA FOR CONTROLLED IL-12 FOR THE TREATMENT OF GLIOBLASTOMA AND DIPG AT THE 2020 SOCIETY FOR NEURO-ONCOLOGY ANNUAL MEETING
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-17 16:15:00
| null |
– PHARMACEUTICAL EXECUTIVE WITH 2 0 + YEAR S OF EXPERIENCE ACROSS ALL PHASES OF CLINICAL RESEARCH INCLUDING IND SUBMISSION S , TRIAL DESIGN AND REGULATORY FILINGS –
|
ZIOPHARM ONCOLOGY APPOINTS RAFFAELE BAFFA, M.D., PH.D., AS CHIEF MEDICAL OFFICER
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-16 08:30:00
| null |
– SPECIAL ADVISOR AND FORMER CHIEF OF STAFF FOR THE BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE JOINS AS INDEPENDENT DIRECTOR –
|
ZIOPHARM ONCOLOGY APPOINTS MARY THISTLE TO BOARD OF DIRECTORS
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-13 09:15:00
| null |
BOSTON, NOV. 13, 2020 (GLOBE NEWSWIRE) -- ZIOPHARM ONCOLOGY, INC. (NASDAQ: ZIOP), TODAY ANNOUNCED THAT LAURENCE COOPER, M.D., PH.D., CHIEF EXECUTIVE OFFICER OF ZIOPHARM, IS SCHEDULED TO PARTICIPATE IN A FIRESIDE CHAT AT THE JEFFERIES VIRTUAL LONDON HEALTHCARE CONFERENCE ON NOVEMBER 19, 2020 AT 1:45 PM ET.
|
ZIOPHARM ONCOLOGY TO PARTICIPATE IN JEFFERIES VIRTUAL LONDON HEALTHCARE CONFERENCE ON NOVEMBER 19, 2020
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-05 09:05:00
| null |
NEW YORK--(BUSINESS WIRE)--WATERMILL ASSET MANAGEMENT CORP. (TOGETHER WITH ITS AFFILIATES, “WATERMILL” OR “WE”), WHICH COLLECTIVELY WITH THE OTHER PARTICIPANTS IN ITS CONSENT SOLICITATION BENEFICIALLY OWNS APPROXIMATELY 3.3% OF THE OUTSTANDING SHARES OF ZIOPHARM ONCOLOGY, INC. (NASDAQ: ZIOP) (“ZIOPHARM” OR THE “COMPANY”), TODAY ISSUED THE BELOW LETTER TO SHAREHOLDERS IN SUPPORT OF THE PROPOSALS INCLUDED IN ITS DEFINITIVE CONSENT STATEMENT FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION O
|
WATERMILL ASSET MANAGEMENT SENDS LETTER TO ZIOPHARM ONCOLOGY SHAREHOLDERS
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-02 09:00:00
| null |
URGES SHAREHOLDERS TO SIGN AND RETURN ZIOPHARM'S GREEN CONSENT REVOCATION CARD
|
ZIOPHARM FILES DEFINITIVE CONSENT REVOCATION STATEMENT AND SENDS LETTER TO SHAREHOLDERS
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-06 19:30:00
| null |
ZIOPHARM ONCOLOGY REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 LOSS PER SHARE $0.09.Q2 EARNINGS PER SHARE ESTIMATE $-0.09 -- REFINITIV IBES DATA.EDEN BIOCELL ON TRACK FOR TAIWAN IND FILING FOR AUTOLOGUS CAR-T CLINICAL TRIAL THIS YEAR.
|
ZIOPHARM ONCOLOGY REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-29 12:30:00
| null |
ZIOPHARM ONCOLOGY PRESENTS ENCOURAGING CLINICAL DATA FOR CONTROLLED IL-12 FOR TREATMENT OF RECURRENT GLIOBLASTOMA AT 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY.ZIOPHARM ONCOLOGY - CONTROLLED IL-12 IN COMBINATION WITH PD-1 INHIBITOR HAS FAVORABLE SAFETY PROFILE AND INITIAL SURVIVAL DATA ARE ENCOURAGING.ZIOPHARM ONCOLOGY -LONGER TERM FOLLOW-UP ON CONTROLLED IL-12 MONOTHERAPY STUDY REINFORCES ENCOURAGING MEDIAN OVERALL SURVIVAL,FAVORABLE SAFETY PROFILE.
|
ZIOPHARM ONCOLOGY PRESENTS ENCOURAGING CLINICAL DATA FOR CONTROLLED IL-12 FOR TREATMENT OF RECURRENT GLIOBLASTOMA AT 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-27 19:30:00
| null |
ZIOPHARM ONCOLOGY ANNOUNCES MANAGEMENT TRANSITION.SAYS PRESIDENT DR DAVID MAUNEY RESIGNED.MAUNEY REMAINS A CONSULTANT TO ZIOPHARM.
|
ZIOPHARM ONCOLOGY SAYS PRESIDENT DAVID MAUNEY RESIGNED
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-05 12:30:00
| null |
ZIOPHARM ONCOLOGY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.ZIOPHARM ONCOLOGY INC - ANNOUNCED PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 27.8 MILLION SHARES AT $3.25 PER SHARE.
|
ZIOPHARM ONCOLOGY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-04 20:30:00
| null |
ZIOPHARM ONCOLOGY ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.ZIOPHARM ONCOLOGY INC - INTENDS TO OFFER AND SELL SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN REGISTERED PUBLIC OFFERING.
|
ZIOPHARM ONCOLOGY ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-14 19:30:00
| null |
ZIOPHARM ONCOLOGY INC - ON JAN 8, 2020, CO ENTERED INTO AMENDMENT TO PATENT LICENSE AGREEMENT WITH NATIONAL CANCER INSTITUTE.ZIOPHARM ONCOLOGY INC - UNDER AMENDMENT, CO EXPANDED TCR LIBRARY LICENSED FROM NCI TO INCLUDE ADDITIONAL TCRS REACTIVE TO MUTATED KRAS & TP53.ZIOPHARM ONCOLOGY INC - UNDER AMENDMENT, COMPANY REQUIRED TO PAY NCI A CASH PAYMENT OF $600,000 WITHIN 60 DAYS OF THE EXECUTION DATE OF THE AMENDMENT.
|
ZIOPHARM ONCOLOGY ENTERS INTO AMENDMENT TO PATENT LICENSE AGREEMENT WITH NATIONAL CANCER INSTITUTE
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-22 22:30:00
| null |
ZIOPHARM ONCOLOGY, INC. ANNOUNCED THE PRESENTATION OF NEW INTERIM ANALYSES OF CLINICAL DATA FROM TWO ONGOING SUBSTUDIES IN ITS CONTROLLED IL-12 PLATFORM, OR AD-RTS-HIL-12 PLUS VELEDIMEX (AD+V), BOTH AS MONOTHERAPY AND IN COMBINATION WITH A PD-1 INHIBITOR, FOR THE TREATMENT OF RECURRENT OR PROGRESSIVE GLIOBLASTOMA MULTIFORME (RGBM) IN ADULTS, AT THE 2019 SOCIETY FOR NEURO-ONCOLOGY (SNO) ANNUAL MEETING IN PHOENIX. INTERIM UPDATE REPORTED: DECREASE IN TUMOR FROM BASELINE (TIME OF AD+V ADMINISTRATION) RESULTING IN A PATIENT’S LESION BEING TOO SMALL TO MEASURE, ASSESSED AS A PARTIAL RESPONSE (PER IRANO), WITH FOLLOW UP ONGOING; SUBJECTS WERE COMPARABLE TO THE MAIN STUDY EXCEPT A HIGHER PERCENTAGE IN THE EXPANSION SUBSTUDY HAD MULTIFOCAL DISEASE VS. UNIFOCAL DISEASE AND FEWER RECURRENCES; BASED ON STUDY DESIGN THERE WAS, AS EXPECTED, A HIGHER PERCENTAGE OF SUBJECTS IN THE EXPANSION SUBSTUDY AS COMPARED WITH MAIN STUDY (75% VS 40%) WHO RECEIVED LOW-DOSE CONCURRENT STEROIDS; LOCAL, REGULATED IL-12 PRODUCTION USING AD+V IN SUBJECTS WITH RGBM RAPIDLY AND SAFELY ACTIVATES THE IMMUNE SYSTEM; PEAK SERUM IL-12 AT DAY 3 WITH DOWNSTREAM PRODUCTION OF ENDOGENOUS IFN-G PEAKING AT DAY 7 IN EXPANSION SUBSTUDY (AND MAIN STUDY); MRI FINDINGS OF PSEUDOPROGRESSION, CONSISTENT WITH IMMUNE-MEDIATED ANTI-TUMOR EFFECTS; 20MG V SUBJECTS (MAIN + EXPANSION, N=20) WITH UNIFOCAL DISEASE AT ENTRY, RECEIVING LOW-DOSE STEROIDS (DEFINED AS <20 MG CUMULATIVE DOSING OF DEXAMETHASONE) CONTINUED TO SHOW A TREND TOWARDS LONGER MEDIAN OVERALL SURVIVAL (MOS, 16.2 MONTHS); ADVERSE REACTIONS (ARS) WERE CONSISTENT WITH PRIOR STUDIES OF AD+V, PREDICTABLE, DOSE-RELATED, AND PROMPTLY REVERSIBLE UPON DISCONTINUATION OF VELEDIMEX; NO DRUG-RELATED DEATHS WERE REPORTED. IN THE MAIN STUDY, SIX SUBJECTS WITH UNIFOCAL DISEASE AT ENTRY, RECEIVING LOW-DOSE STEROIDS (DEFINED AS <20 MG CUMULATIVE DOSING OF DEXAMETHASONE) WERE PREVIOUSLY REPORTED TO HAVE MOS OF 17.8 MONTHS. THE MOS FOR THESE PATIENTS IN THE EXPANSION SUBSTUDY (N=14) HAS NOT BEEN REACHED AT A MEAN FOLLOW UP OF 9.7 MONTHS. LITERATURE SHOWS THAT MULTIFOCAL GBM IS ASSOCIATED WITH WORSE PROGNOSIS COMPARED TO UNIFOCAL DISEASE.1,2 THE DATA FROM THE MAIN STUDY AND THE EXPANSION SUBSTUDY ARE CONSISTENT WITH THIS PROGNOSIS, WITH MOS OF 10.1 MONTHS FOR PATIENTS (N=13) WITH MULTIFOCAL DISEASE AT ENTRY THAT RECEIVED 20MG VELEDIMEX AND LOW-DOSE STEROIDS.
|
ZIOPHARM ONCOLOGY, INC. PRESENTS CLINICAL DATA FOR CONTROLLED IL-12 FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-07 19:30:00
| null |
ZIOPHARM ONCOLOGY REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.43.Q3 EARNINGS PER SHARE ESTIMATE $-0.09 -- REFINITIV IBES DATA.IN Q3 RECORDED A ONE-TIME, NON-CASH CHARGE DURING QUARTER OF $60.8 MILLION ASSOCIATED WITH WARRANT EXERCISE TRANSACTION.QTRLY LOSS PER SHARE $0.43.ZIOPHARM ONCOLOGY - ENDED QUARTER WITH UNRESTRICTED CASH RESOURCES OF ABOUT $88 MILLION.
|
ZIOPHARM ONCOLOGY POSTS Q3 LOSS PER SHARE OF $0.43
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-06 22:30:00
| null |
ZIOPHARM ONCOLOGY, INC. ANNOUNCED EARNINGS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2019. FOR THE THIRD QUARTER, THE COMPANY ANNOUNCED OPERATING LOSS WAS USD 13.448 MILLION COMPARED TO USD 12.570 MILLION A YEAR AGO. NET LOSS WAS USD 73.996 MILLION COMPARED TO USD 12.585 MILLION A YEAR AGO. BASIC LOSS PER SHARE WAS USD 0.43 COMPARED TO USD 0.13 A YEAR AGO. FOR THE NINE MONTHS, OPERATING LOSS WAS USD 41.822 MILLION COMPARED TO USD 41.144 MILLION A YEAR AGO. NET LOSS WAS USD 102.050 MILLION COMPARED TO USD 40.636 MILLION A YEAR AGO. BASIC LOSS PER SHARE WAS USD 0.62 COMPARED TO USD 0.41 A YEAR AGO.
|
ZIOPHARM ONCOLOGY, INC. REPORTS EARNINGS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2019
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-29 22:30:00
| null |
ZIOPHARM ONCOLOGY, INC., Q3 2019 EARNINGS CALL, NOV 07, 2019
|
ZIOPHARM ONCOLOGY, INC., Q3 2019 EARNINGS CALL, NOV 07, 2019
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-28 10:30:00
| null |
ZIOPHARM ONCOLOGY AND MD ANDERSON CANCER CENTER ANNOUNCE NEW RESEARCH AND DEVELOPMENT AGREEMENT TO EXPAND TCR-T PROGRAM.ZIOPHARM ONCOLOGY INC - COMMITS TO FUND AN ADDITIONAL $20 MILLION FOR THIS EXPANDED WORK IN TCR-T PROGRAM THROUGH 2023.ZIOPHARM ONCOLOGY INC - FUNDING FOR NEW AGREEMENT WAS INCLUDED WITHIN BUDGET FORECAST PROVIDED BY ZIOPHARM IN ITS Q2 2019.
|
ZIOPHARM ONCOLOGY AND MD ANDERSON CANCER CENTER ANNOUNCE NEW RESEARCH AND DEVELOPMENT AGREEMENT TO EXPAND TCR-T PROGRAM
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-27 22:30:00
| null |
ON OCTOBER 22, 2019, ZIOPHARM ONCOLOGY, INC. AND THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER ENTERED INTO THE 2019 RESEARCH AND DEVELOPMENT AGREEMENT (THE 2019 AGREEMENT) PURSUANT TO WHICH THE PARTIES AGREED TO COLLABORATE WITH RESPECT TO THE COMPANY'S SLEEPING BEAUTY IMMUNOTHERAPY PROGRAM, WHICH USES NON-VIRAL GENE TRANSFER TO STABLY EXPRESS AND CLINICALLY EVALUATE NEOANTIGEN-SPECIFIC T-CELL RECEPTORS (TCRS) IN T CELLS. UNDER THE 2019 AGREEMENT, THE COMPANY AND MD ANDERSON WILL, AMONG OTHER THINGS, COLLABORATE ON PROGRAMS TO EXPAND THE COMPANY'S TCR LIBRARY AND CONDUCT CLINICAL TRIALS. THE ACTIVITIES UNDER THE 2019 AGREEMENT WILL BE DIRECTED BY A JOINT STEERING COMMITTEE COMPRISED OF TWO MEMBERS FROM THE COMPANY AND ONE MEMBER FROM MD ANDERSON. ZIOPHARM WILL OWN ALL INTELLECTUAL PROPERTY DEVELOPED UNDER THE 2019 AGREEMENT AND WILL RETAIN ALL RIGHTS TO INTELLECTUAL PROPERTY FOR ONCOLOGY PRODUCTS MANUFACTURED USING NON-VIRAL GENE TRANSFER TECHNOLOGIES UNDER THE AGREEMENT, INCLUDING THE COMPANY'S SLEEPING BEAUTY TECHNOLOGY. ZIOPHARM HAS GRANTED MD ANDERSON AN EXCLUSIVE LICENSE FOR SUCH INTELLECTUAL PROPERTY OUTSIDE THE FIELD OF ONCOLOGY AND TO DEVELOP AND COMMERCIALIZE AUTOLOGOUS TCR PRODUCTS MANUFACTURED USING VIRAL GENE TRANSFER TECHNOLOGIES, AND A NON-EXCLUSIVE LICENSE FOR ALLOGENEIC TCR PRODUCTS MANUFACTURED USING VIRAL-BASED TECHNOLOGIES. THE COMPANY HAS AGREED, BEGINNING ON JANUARY 1, 2021, TO REIMBURSE MD ANDERSON UP TO A TOTAL OF $20 MILLION FOR DEVELOPMENT COSTS UNDER THE 2019 AGREEMENT. IN ADDITION, THE COMPANY WILL PAY MD ANDERSON ROYALTIES ON NET SALES OF ITS TCR PRODUCTS AT RATES IN THE LOW SINGLE DIGITS. THE COMPANY IS REQUIRED TO MAKE PERFORMANCE-BASED PAYMENTS UPON THE SUCCESSFUL COMPLETION OF CLINICAL AND REGULATORY BENCHMARKS RELATING TO ITS TCR PRODUCTS. THE AGGREGATE POTENTIAL BENCHMARK PAYMENTS ARE $36.5 MILLION, OF WHICH ONLY $3.0 MILLION WILL BE DUE PRIOR TO THE FIRST MARKETING APPROVAL OF THE COMPANY'S TCR PRODUCTS. THE ROYALTY RATES AND BENCHMARK PAYMENTS OWED TO MD ANDERSON MAY BE REDUCED UPON THE OCCURRENCE OF CERTAIN EVENTS. THE COMPANY ALSO AGREED THAT IT WILL SELL ITS TCR PRODUCTS TO MD ANDERSON AT PREFERENTIAL PRICES, AND WILL SELL ITS TCR PRODUCTS IN TEXAS EXCLUSIVELY TO MD ANDERSON FOR A LIMITED PERIOD OF TIME FOLLOWING THE FIRST COMMERCIAL SALE OF THE COMPANY'S TCR PRODUCTS. THE 2019 AGREEMENT WILL TERMINATE ON DECEMBER 31, 2026 AND EITHER PARTY MAY TERMINATE THE 2019 AGREEMENT FOLLOWING WRITTEN NOTICE OF A MATERIAL BREACH. THE 2019 AGREEMENT ALSO CONTAINS CUSTOMARY PROVISIONS RELATED TO INDEMNIFICATION OBLIGATIONS, CONFIDENTIALITY AND OTHER MATTERS.
|
ZIOPHARM ONCOLOGY, INC. AND THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER ENTER INTO THE 2019 RESEARCH AND DEVELOPMENT AGREEMENT
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-22 22:30:00
| null |
ZIOPHARM ONCOLOGY, INC. HAS FILED A SHELF REGISTRATION IN THE AMOUNT OF $77.265155 MILLION.
SECURITY NAME: COMMON STOCK
SECURITIES OFFERED: 17,803,031
|
ZIOPHARM ONCOLOGY, INC. HAS FILED A SHELF REGISTRATION IN THE AMOUNT OF $77.265155 MILLION.
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-14 22:30:00
| null |
ZIOPHARM ONCOLOGY, INC. ANNOUNCED THAT CHRIS BOWDEN HAS BEEN APPOINTED TO THE COMPANY’S BOARD OF DIRECTORS. DR. BOWDEN IS THE CHIEF MEDICAL OFFICER OF AGIOS PHARMACEUTICALS AND WAS PREVIOUSLY VICE PRESIDENT, PRODUCT DEVELOPMENT ONCOLOGY, AT GENENTECH, INC., A MEMBER OF THE ROCHE GROUP.
|
ZIOPHARM ONCOLOGY, INC. NAMES CHRIS BOWDEN TO BOARD OF DIRECTORS
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-02 22:30:00
| null |
ZIOPHARM ONCOLOGY, INC. PRESENTS AT 2ND ANNUAL ADVANCES IN IMMUNO-ONCOLOGY, OCT-08-2019 09:00 AM. VENUE: DOUBLETREE BY HILTON HOTEL SAN DIEGO – MISSION VALLEY, 7450 HAZARD CENTER DRIVE, SAN DIEGO, CALIFORNIA, UNITED STATES. SPEAKERS: LAURENCE JAMES NEIL COOPER, CEO & DIRECTOR.
|
ZIOPHARM ONCOLOGY, INC. PRESENTS AT 2ND ANNUAL ADVANCES IN IMMUNO-ONCOLOGY, OCT-08-2019 09:00 AM
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-09-30 22:30:00
| null |
ZIOPHARM ONCOLOGY, INC. ANNOUNCED THAT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS CLEARED AN INVESTIGATIONAL NEW DRUG APPLICATION (IND) FOR A PHASE 1 CLINICAL TRIAL TO EVALUATE CD19-SPECIFIC CAR-T, PRODUCED USING A PROCESS TERMED RAPID PERSONALIZED MANUFACTURE (RPM), AS AN INVESTIGATIONAL TREATMENT FOR PATIENTS WITH RELAPSED CD19+ LEUKEMIAS AND LYMPHOMAS. THE IND CLEARANCE BUILDS UPON THE COMPANY’S EXPERIENCE WITH TWO PRIOR GENERATIONS OF IMMUNOTHERAPY TRIALS USING THE SLEEPING BEAUTY PLATFORM, WHICH IT BELIEVES IS THE MOST CLINICALLY-ADVANCED NON-VIRAL APPROACH TO THE GENETIC MODIFICATION OF T CELLS. WITH THIS THIRD-GENERATION TRIAL, DNA FROM THE SLEEPING BEAUTY SYSTEM IS STABLY INSERTED INTO THE GENOME OF RESTING T CELLS TO CO-EXPRESS A CHIMERIC ANTIGEN RECEPTOR (CAR), MEMBRANE-BOUND IL-15 (MBIL15) AND A SAFETY SWITCH, WHICH IS DESIGNED TO REDUCE COST, SIMPLIFY PRODUCTION, AND PRESERVE THE THERAPEUTIC POTENTIAL OF THE T CELLS. UP TO 24 PATIENTS WILL BE ENROLLED TO EVALUATE INFUSION OF DONOR-DERIVED RPM CAR-T IN PATIENTS WITH CD19+ LEUKEMIAS AND LYMPHOMAS WHO HAVE RELAPSED AFTER ALLOGENEIC BMT. THIS STUDY WILL BE CONDUCTED AT THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER UNDER AN INVESTIGATOR-INITIATED TRIAL EXPECTED TO BEGIN LATER THIS YEAR.
|
ZIOPHARM ONCOLOGY, INC. ANNOUNCES FDA CLEARANCE OF IND FOR RAPID PERSONALIZED MANUFACTURE OF CD19-SPECIFIC CAR-T
|
ZIOP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-03 11:00:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)--ZIPRECRUITER®, A LEADING ONLINE EMPLOYMENT MARKETPLACE, TODAY RELEASED ITS SECOND ANNUAL GRAD REPORT, THE CLASS OF 2023: A STORY OF RESILIENCE, REVEALING THAT MORE THAN TWO-THIRDS OF THE GRADUATING CLASS FEEL THEY ARE VERY PREPARED (69%) FOR THE CURRENT LABOR MARKET. THE MAJORITY OF GRADUATES (92%) STARTED ACTIVELY APPLYING FOR JOBS AS OF EARLY APRIL AND 85% SAID THEY HAVE ALREADY BEEN RECRUITED. WITH AN AVERAGE OF NINE JOB INTERVIEWS UNDER THEIR BELTS, TH.
|
ZIPRECRUITER FINDS CLASS OF 2023 GRADS FEEL PREPARED FOR ENTRY INTO LABOR MARKET
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-13 18:30:00
| null |
NEW YORK , MARCH 13, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZIPRECRUITER, INC. ("ZIPRECRUITER" OR THE "COMPANY") (NYSE: ZIP). SUCH INVESTORS ARE ADVISED TO CONTACT ROBERT S.
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ZIPRECRUITER, INC. - ZIP
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-23 21:41:00
| null |
NEW YORK , FEB. 23, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZIPRECRUITER, INC. ("ZIPRECRUITER" OR THE "COMPANY") (NYSE: ZIP). SUCH INVESTORS ARE ADVISED TO CONTACT ROBERT S.
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ZIPRECRUITER, INC. - ZIP
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-23 12:48:00
| null |
NEW YORK , FEB. 23, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZIPRECRUITER, INC. ("ZIPRECRUITER" OR THE "COMPANY") (NYSE: ZIP). SUCH INVESTORS ARE ADVISED TO CONTACT ROBERT S.
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ZIPRECRUITER, INC. - ZIP
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-12-16 17:00:00
| null |
SANTA MONICA, CALIF.--( BUSINESS WIRE )--ZIPRECRUITER®, A LEADING ONLINE EMPLOYMENT MARKETPLACE, TODAY ANNOUNCED THAT IT HAS ENTERED INTO AN ACCELERATED SHARE REPURCHASE AGREEMENT (“ASR”) WITH WELLS FARGO BANK, NATIONAL ASSOCIATION, TO REPURCHASE $50.0 MILLION OF ZIPRECRUITER'S COMMON STOCK.
|
ZIPRECRUITER ANNOUNCES $50 MILLION ACCELERATED SHARE REPURCHASE
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-16 19:20:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)--ZIPRECRUITER® (NYSE:ZIP), A LEADING ONLINE EMPLOYMENT MARKETPLACE, TODAY ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED A $150 MILLION INCREASE TO THE COMPANY'S SHARE REPURCHASE PROGRAM. THIS IS IN ADDITION TO THE PREVIOUS AUTHORIZATION OF $100 MILLION. AS OF JUNE 15, 2022, APPROXIMATELY $6.6 MILLION IN SHARES OF THE COMPANY'S CLASS A COMMON STOCK WAS AVAILABLE FOR FUTURE REPURCHASES UNDER THE COMPANY'S SHARE REPURCHASE PROGRAM. AS A RESULT OF THE INCREAS
|
ZIPRECRUITER ANNOUNCES $150 MILLION INCREASE TO SHARE REPURCHASE PROGRAM
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-25 11:00:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)--TODAY ZIPRECRUITER RELEASED ITS INAUGURAL REPORT, “THE CLASS OF 2022: THE JOB MARKET OUTLOOK FOR GRADS” REVEALING THAT NEWLY MINTED COLLEGE GRADUATES ARE ENTERING A SIZZLING JOB MARKET WITH TWO JOB OPENINGS FOR EVERY UNEMPLOYED PERSON1. EMPLOYERS ARE ROLLING OUT THE RED CARPET TO GRADS WITH PERKS LIKE SIGNING BONUSES (NEARLY 800%2 GROWTH IN RECENT YEARS), REMOTE WORK OPTIONS, HELP WITH STUDENT LOAN PAYMENTS, AND VACATION STIPENDS. “YOUNG PEOPLE SPEND A LAR
|
ZIPRECRUITER REPORT FINDS RED HOT JOB MARKET FOR 2022 COLLEGE GRADS
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-21 08:00:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)--ZIPRECRUITER, INC. (NYSE:ZIP), A LEADING ONLINE EMPLOYMENT MARKETPLACE, TODAY ANNOUNCED THAT IT HAS ENTERED INTO AN ACCELERATED SHARE REPURCHASE AGREEMENT (“ASR”) WITH GOLDMAN SACHS & CO. LLC TO REPURCHASE $50 MILLION OF ZIPRECRUITER'S COMMON STOCK. UNDER THE ASR, ZIPRECRUITER WILL MAKE AN INITIAL PAYMENT OF $50 MILLION TO GOLDMAN SACHS & CO. LLC AND WILL RECEIVE AN INITIAL DELIVERY OF APPROXIMATELY 1.8 MILLION SHARES OF ITS COMMON STOCK BY MARCH 2
|
ZIPRECRUITER ANNOUNCES $50 MILLION ACCELERATED SHARE REPURCHASE
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-26 12:04:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)-- #JOBS--ZIPRECRUITER HAS BEEN HONORED BY G2, THE WORLD'S LEADING BUSINESS SOLUTION REVIEW PLATFORM, WITH TEN WINTER AWARDS INCLUDING EASIEST TO USE, USERS MOST LIKELY TO RECOMMEND, AND LEADER ACROSS SMALL, MID-SIZE, AND ENTERPRISE BUSINESSES. THE FULL LIST OF AWARDS WON IS: BEST RELATIONSHIP MID-MARKET BEST RELATIONSHIP SMALL BUSINESS BEST USABILITY EASIEST TO USE LEADER ENTERPRISE LEADER LEADER MID-MARKET LEADER SMALL-BUSINESS MOMENTUM LEADER USERS MOST LIKELY TO
|
ZIPRECRUITER WINS G2 AWARDS INCLUDING EASIEST TO USE AND USERS MOST LIKELY TO RECOMMEND
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-07 18:30:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)--ZIPRECRUITER® (NYSE: ZIP) TODAY ANNOUNCED THE PRICING OF $550 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 5.000% SENIOR NOTES DUE 2030 (THE “NOTES”) IN ITS PREVIOUSLY ANNOUNCED PRIVATE OFFERING (THE “OFFERING”). THE AGGREGATE PRINCIPAL AMOUNT OF THE OFFERING WAS INCREASED FROM THE PREVIOUSLY ANNOUNCED OFFERING SIZE OF $500 MILLION DUE TO MARKET INTEREST. THE OFFERING IS EXPECTED TO CLOSE ON JANUARY 12, 2022, SUBJECT TO SATISFACTION OF CUSTOMARY CLOSING CONDI
|
ZIPRECRUITER ANNOUNCES THE UPSIZE AND PRICING OF $550 MILLION OF SENIOR NOTES DUE 2030
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-07 11:30:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)-- #JOBS--ZIPRECRUITER IS ONE OF BUILT IN'S 2022 BEST PLACES TO WORK
|
BUILT IN HONORS ZIPRECRUITER IN ITS ESTEEMED 2022 BEST PLACES TO WORK AWARDS
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-05 07:15:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)--ZIPRECRUITER® (NYSE: ZIP) TODAY ANNOUNCED ITS INTENTION TO OFFER, SUBJECT TO MARKET CONDITIONS AND OTHER FACTORS, $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS SENIOR NOTES DUE 2030 (THE “NOTES”) IN A PRIVATE OFFERING (THE “OFFERING”). THE INTEREST RATE, REDEMPTION PROVISIONS, AND OTHER TERMS OF THE NOTES WILL BE DETERMINED BY NEGOTIATIONS BETWEEN ZIPRECRUITER AND THE INITIAL PURCHASERS. ZIPRECRUITER INTENDS TO USE THE NET PROCEEDS FROM THE OFFERING FOR G
|
ZIPRECRUITER ANNOUNCES PROPOSED PRIVATE OFFERING OF $500 MILLION OF SENIOR NOTES DUE 2030
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-17 11:28:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)-- #JOBS--ZIPRECRUITER WINS FOUR COMPARABLY AWARDS
|
ZIPRECRUITER WINS COMPARABLY AWARDS FOR BEST CEOS, BEST COMPANY CULTURE, BEST COMPANIES FOR WOMEN, AND BEST COMPANIES FOR DIVERSITY
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-06 12:13:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)-- #HR--ZIPRECRUITER WINS COMPARABLY AWARDS FOR BEST WORK-LIFE BALANCE AND HAPPIEST EMPLOYEES
|
ZIPRECRUITER WINS COMPARABLY AWARDS FOR BEST WORK-LIFE BALANCE AND HAPPIEST EMPLOYEES
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-15 12:00:00
| null |
SANTA MONICA, CALIF.--(BUSINESS WIRE)-- #JOBS--ZIPRECRUITER HAS ONCE AGAIN BEEN RECOGNIZED WITH A COMPARABLY AWARD HIGHLIGHTING THE BEST COMPANIES, THIS TIME WINNING THE BEST CAREER GROWTH HONOR. “IN ANNUAL SURVEYS OF JOB SEEKERS AND EMPLOYEES NATIONWIDE, THE NUMBER ONE REASON PEOPLE CITE FOR WANTING TO SWITCH JOBS IS THAT THEY FEEL THEY HAVE NO ROOM TO GROW IN THEIR CAREERS. CAREER GROWTH POTENTIAL IS AMONG THE MOST IMPORTANT ASPECTS OF A JOB TO EMPLOYEES, SECOND ONLY TO SALARY,” SAID ZIPRECRUITER CEO
|
ZIPRECRUITER WINS COMPARABLY AWARD FOR BEST CAREER GROWTH
|
ZIP
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-06-30 13:55:00
| null |
BLOOMFIELD HILLS, MICH.--(BUSINESS WIRE)--ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES DERIVED FROM PROPRIETARY ALGAL CULTURES, TODAY ANNOUNCED THAT IT HAS ENTERED INTO A SECURITIES PURCHASE AGREEMENT WITH A SINGLE INSTITUTIONAL INVESTOR TO PURCHASE 1,498,130 SHARES OF COMMON STOCK (OR PRE-FUNDED WARRANTS IN LIEU THEREOF) IN A REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NA.
|
ZIVO BIOSCIENCE ANNOUNCES PRICING OF $4.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-04-05 16:05:00
| null |
BLOOMFIELD HILLS, MICH.--(BUSINESS WIRE)--ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO) (THE “COMPANY”), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES DERIVED FROM PROPRIETARY ALGAL CULTURES, TODAY ANNOUNCED A $1 MILLION UNSECURED SIX-MONTH LOAN FROM ITS CHAIRMAN, CHIEF EXECUTIVE OFFICER, AND PRESIDENT, JOHN PAYNE.
|
ZIVO BIOSCIENCE RECEIVES $1 MILLION BRIDGE FINANCING
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-10 16:37:00
| null |
BLOOMFIELD HILLS, MICH.--(BUSINESS WIRE)--ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO) (THE “COMPANY”), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES DERIVED FROM PROPRIETARY ALGAL CULTURES, TODAY ANNOUNCED THE RESULTS OF A FOUR-MONTH STUDY PERFORMED BY A THIRD PARTY ON BEHALF OF A POTENTIAL PARTNER COMPANY, WHICH INCLUDED A 42-DAY COCCIDIOSIS TRIAL IN BROILER CHICKENS.
|
ZIVO BIOSCIENCE ANNOUNCES RESULTS OF STUDY WITH ITS PRODUCT CANDIDATE FOR THE PREVENTION AND TREATMENT OF COCCIDIOSIS IN BROILER CHICKENS
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-23 08:00:00
| null |
BLOOMFIELD HILLS, MICH.--(BUSINESS WIRE)--ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES DERIVED FROM PROPRIETARY ALGAL CULTURES, TODAY ISSUED THE FOLLOWING LETTER TO SHAREHOLDERS FROM ITS CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER, JOHN PAYNE. TO MY FELLOW SHAREHOLDERS, HAVING SERVED AS A MEMBER OF THE BOARD OF DIRECTORS OF ZIVO BIOSCIENCE SINCE 2013 AND AS CHAIRMAN SINCE 2019,
|
ZIVO BIOSCIENCE CEO ISSUES LETTER TO SHAREHOLDERS
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-10 16:15:00
| null |
BLOOMFIELD HILLS, MICH.--(BUSINESS WIRE)--ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO) (THE “COMPANY”), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES DERIVED FROM PROPRIETARY ALGAL CULTURES, ANNOUNCES RECEIPT OF A LETTER FROM THE U.S. DEPARTMENT OF AGRICULTURE'S (USDA) CENTER FOR VETERINARY BIOLOGICS (CVB) AFFIRMING THAT THE AGENCY HAS CLAIMED JURISDICTION FOR REVIEWING THE COMPANY'S NOVEL IMMUNE-MODULATING BIOLOGIC FOR TREATING
|
ZIVO REPORTS THAT USDA CLAIMS REGULATORY JURISDICTION FOR NEW COCCIDIOSIS TREATMENT
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-27 08:00:00
| null |
BLOOMFIELD HILLS, MICH.--(BUSINESS WIRE)--ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO) (THE “COMPANY”), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES DERIVED FROM PROPRIETARY ALGAL CULTURES, TODAY ANNOUNCED THAT, EFFECTIVE TODAY, JUNE 27, 2022, IT HAS JOINED THE RUSSELL MICROCAP® INDEX (^RUMIC) AS A RESULT OF THE 2022 RUSSELL INDEXES ANNUAL RECONSTITUTION. MEMBERSHIP IN THE RUSSELL MICROCAP® INDEX, WHICH REMAINS IN PLACE FOR ONE
|
ZIVO BIOSCIENCE JOINS RUSSELL MICROCAP® INDEX
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-10 17:00:00
| null |
KEEGO HARBOR, MICH.--(BUSINESS WIRE)--ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO) (“ZIVO” OR THE “COMPANY”), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT AND COMMERCIALIZATION OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES DERIVED FROM PROPRIETARY ALGAL CULTURES, ANNOUNCES THAT CHAIRMAN OF THE BOARD JOHN B. PAYNE HAS BEEN NAMED PRESIDENT AND CHIEF EXECUTIVE OFFICER OF THE COMPANY. MR. PAYNE SUCCEEDS ANDREW A. DAHL. “I AM HONORED TO ASSUME THE EXECUTIVE LEADERSHIP OF ZIVO B
|
ZIVO BIOSCIENCE NAMES CHAIRMAN JOHN B. PAYNE AS PRESIDENT AND CEO
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-02 08:00:00
| null |
KEEGO HARBOR, MICH., JULY 02, 2021 (GLOBE NEWSWIRE) -- ZIVO BIOSCIENCE, INC. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” AND THE “COMPANY”), A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT AND COMMERCIALIZATION OF THERAPEUTIC, MEDICINAL AND NUTRITIONAL PRODUCT CANDIDATES ORIGINALLY DERIVED FROM PROPRIETARY ALGAL CULTURES, TODAY ANNOUNCED THE CLOSING OF THE SALE OF AN ADDITIONAL 150,000 SHARES OF COMMON STOCK, AT A PRICE TO THE PUBLIC OF $4.99 PER SHARE LESS UNDERWRITING DISCOUNTS AND COMMISSIONS, PURSUANT TO THE PARTIAL EXERCISE OF THE UNDERWRITERS' OVER-ALLOTMENT OPTION IN CONNECTION WITH ITS PREVIOUSLY ANNOUNCED PUBLIC OFFERING THAT CLOSED ON JUNE 2, 2021. ZIVO RECEIVED GROSS PROCEEDS OF APPROXIMATELY $748,500, BEFORE DEDUCTING UNDERWRITING DISCOUNTS AND COMMISSIONS AND OTHER ESTIMATED OFFERING EXPENSES.
|
ZIVO BIOSCIENCE, INC. ANNOUNCES CLOSING OF UNDERWRITERS' PARTIAL EXERCISE OF OVER-ALLOTMENT OPTION IN CONNECTION WITH ITS PREVIOUSLY ANNOUNCED PUBLIC OFFERING
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-27 20:42:00
| null |
KEEGO HARBOR, MICH., MAY 27, 2021 (GLOBE NEWSWIRE) -- ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO) A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT AND COMMERCIALIZATION OF NUTRITIONAL/NUTRACEUTICAL PRODUCT CANDIDATES ORIGINALLY DERIVED FROM PROPRIETARY ALGAL CULTURES, TODAY ANNOUNCED THE PRICING OF ITS UPSIZED UNDERWRITTEN PUBLIC OFFERING OF 2,760,000 UNITS AT A PRICE TO THE PUBLIC OF $5.00 PER UNIT. EACH UNIT TO BE ISSUED IN THE OFFERING CONSISTS OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK AT AN EXERCISE PRICE OF $5.50. THE COMMON STOCK AND WARRANTS ARE IMMEDIATELY SEPARABLE AND WILL BE ISSUED SEPARATELY. THE COMMON STOCK AND WARRANTS ARE EXPECTED TO BEGIN TRADING ON THE NASDAQ CAPITAL MARKET, ON MAY 28, 2021, UNDER THE SYMBOLS “ZIVO” AND “ZIVOW,” RESPECTIVELY. ZIVO EXPECTS TO RECEIVE GROSS PROCEEDS OF $13.8 MILLION, BEFORE DEDUCTING UNDERWRITING DISCOUNTS AND COMMISSIONS AND OTHER ESTIMATED OFFERING EXPENSES. IN CONNECTION WITH THE OFFERING, THE COMPANY WILL EFFECTUATE A REVERSE SPLIT OF ITS ISSUED AND OUTSTANDING COMMON STOCK AT A RATIO OF 1-FOR-80. THE REVERSE STOCK SPLIT IS EXPECTED TO BE EFFECTIVE AT 12:01 A.M., EASTERN TIME, ON MAY 28, 2021. THE SHARE NUMBERS AND PRICING INFORMATION IN THIS RELEASE ARE ADJUSTED TO GIVE EFFECT TO THE REVERSE STOCK SPLIT.
|
ZIVO BIOSCIENCE, INC. ANNOUNCES PRICING OF UPSIZED $13.8 MILLION PUBLIC OFFERING AND UP-LISTING TO NASDAQ
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-26 12:06:00
| null |
KEEGO HARBOR, MICH., APRIL 26, 2021 (GLOBE NEWSWIRE) -- ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO) A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT AND COMMERCIALIZATION OF NUTRITIONAL/NUTRACEUTICAL PRODUCT CANDIDATES ORIGINALLY DERIVED FROM PROPRIETARY ALGAL CULTURES, ANNOUNCES TODAY THE US PATENT OFFICE HAS ISSUED A NOTICE OF ALLOWANCE FOR THE USE OF THE COMPANY'S PROPRIETARY ALGAL BIOMASS PRODUCT TO PROMOTE A HEALTHY IMMUNE RESPONSE FOR USE IN DAIRY CATTLE. FOLLOW-ON PATENT FILINGS FOR OTHER ANIMAL SPECIES AND HUMANS ARE IN PROCESS.
|
ZIVO BIOSCIENCE ANNOUNCES US PATENT OFFICE NOTICE OF ALLOWANCE FOR ADMINISTRATION OF PROPRIETARY ALGAL BIOMASS TO SUPPORT IMMUNE HEALTH
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-11 14:50:00
| null |
KEEGO HARBOR, MI / ACCESSWIRE / JANUARY 11, 2021 / ZIVO BIOSCIENCE, INC. (OTCQB:ZIVO) A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT AND COMMERCIALIZATION OF THERAPEUTIC/ADDITIVE PRODUCT CANDIDATES ORIGINALLY DERIVED FROM PROPRIETARY ALGAL CULTURES, ANNOUNCES TODAY THAT IN ITS RECENT ANALYSIS OF TWO POULTRY STUDIES PERFORMED AT SEPARATE RESEARCH FACILITIES, ZIVO PRODUCT CANDIDATES PROVIDED STATISTICALLY SIGNIFICANT FEED CONVERSION BENEFITS IN HEALTHY BROILER FLOCKS EXPOSED TO PATHOGENS PRESENT IN LITTER FROM PREVIOUS FLOCKS, EMULATING EXPOSURE THAT MAY OCCUR IN A TYPICAL BROILER PRODUCTION ENVIRONMENT. ZIVO HAS BEEN DEVELOPING A PRODUCT CANDIDATE DESIGNED TO BOOST IMMUNE RESPONSE AND COMBATTING A BROAD RANGE OF INFECTIVE PATHOGENS, WITH THE GOAL OF IMPROVING FEED CONVERSION AND PRODUCTIVITY TO PROVIDE COST-SAVINGS FOR POULTRY PRODUCERS.
|
ZIVO BIOSCIENCE SUCCESSFULLY CONFIRMS POULTRY GROWTH PROMOTION AND FEED CONVERSION RATIO IMPROVEMENTS IN TYPICAL PRODUCTION ENVIRONMENTS
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-07 16:35:00
| null |
KEEGO HARBOR, MI / ACCESSWIRE / JANUARY 7, 2021 / ZIVO BIOSCIENCE, INC. (OTCMQB:ZIVO) A BIOTECH/AGTECH R&D COMPANY ENGAGED IN THE DEVELOPMENT AND COMMERCIALIZATION OF THERAPEUTIC, FOOD AND FEED ADDITIVE PRODUCTS ANNOUNCED TODAY THAT KEITH R. MARCHIANDO JOINED THE COMPANY'S AS CHIEF FINANCIAL OFFICER, TREASURER, AND SECRETARY, EFFECTIVE JANUARY 1, 2021.
|
ZIVO BIOSCIENCE NAMES KEITH R. MARCHIANDO AS CHIEF FINANCIAL OFFICER
|
ZIVO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-09 12:54:00
| null |
NEW YORK, NOV. 9, 2021 /PRNEWSWIRE/ -- JUAN MONTEVERDE , FOUNDER AND MANAGING PARTNER AT MONTEVERDE & ASSOCIATES PC, A NATIONAL SECURITIES FIRM RATED TOP 50 IN THE 2018-2020 ISS SECURITIES CLASS ACTION SERVICES REPORT AND HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY, IS INVESTIGATING ZIX CORP. (ZIXI) RELATING TO ITS PROPOSED ACQUISITION BY OPEN TEXT CORP. UNDER THE TERMS OF THE AGREEMENT, ZIXI SHAREHOLDERS ARE EXPECTED TO RECEIVE $8.50 IN CASH PER SHARE THEY OWN. THE INVESTIGATION FOCUSES ON WHETHER ZIX CORP. AND ITS BOARD OF DIRECTORS VIOLATED SECURITIES LAWS AND/OR BREACHED THEIR FIDUCIARY DUTIES TO THE COMPANY BY 1) FAILING TO CONDUCT A FAIR PROCESS, AND 2) WHETHER THE TRANSACTION IS PROPERLY VALUED.
|
SHAREHOLDER ALERT: MONTEVERDE & ASSOCIATES PC ANNOUNCES AN INVESTIGATION OF ZIX CORP. - ZIXI
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-08 22:30:00
| null |
NEW YORK, NOV. 8, 2021 /PRNEWSWIRE/ -- ROWLEY LAW PLLC IS INVESTIGATING POTENTIAL SECURITIES LAW VIOLATIONS BY ZIX CORPORATION (NASDAQ: ZIXI) AND ITS BOARD OF DIRECTORS CONCERNING THE PROPOSED ACQUISITION OF THE COMPANY BY OPENTEXT. STOCKHOLDERS WILL RECEIVE $8.50 FOR EACH SHARE OF ZIX CORPORATION STOCK THAT THEY HOLD.
|
ALERT: ROWLEY LAW PLLC IS INVESTIGATING PROPOSED ACQUISITION OF ZIX CORPORATION
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-08 20:18:00
| null |
NEW YORK, NOV. 8, 2021 /PRNEWSWIRE/ -- WEISSLAW LLP IS INVESTIGATING POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW BY THE BOARD OF DIRECTORS OF ZIX CORPORATION ("ZIX" OR THE "COMPANY") (NASDAQ: ZIXI), IN CONNECTION WITH THE PROPOSED ACQUISITION OF THE COMPANY BY OPEN TEXT CORPORATION ("OPENTEXT") (NASDAQ: OTEX) VIA A TENDER OFFER. UNDER THE TERMS OF THE MERGER AGREEMENT, THE COMPANY'S SHAREHOLDERS WILL RECEIVE $8.50 PER SHARE IN CASH FOR EACH SHARE OF ZIX COMMON STOCK THAT THEY HOLD.
|
SHAREHOLDER ALERT: WEISSLAW LLP INVESTIGATES ZIX CORPORATION
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-08 12:53:00
| null |
MILWAUKEE, NOV. 8, 2021 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING ZIX (NASDAQ: ZIXI), FOR POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW IN ITS TRANSACTION WITH OPENTEXT. CLICK HERE TO LEARN HOW TO JOIN THE ACTION: HTTPS://WWW.ADEMILAW.COM/CASE/ZIX-CORPORATION OR CALL GURI ADEMI TOLL-FREE AT 866-264-3995.
|
SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER ZIX CORPORATION HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH OPENTEXT
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-08 09:35:00
| null |
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLP, A GLOBAL INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER THE SALE OF ZIX CORPORATION (NASDAQ: ZIXI) TO OPEN TEXT CORPORATION FOR $8.50 PER SHARE IN CASH IS FAIR TO ZIX SHAREHOLDERS. HALPER SADEH ENCOURAGES ZIX SHAREHOLDERS TO CLICK HERE TO LEARN MORE ABOUT THEIR LEGAL RIGHTS AND OPTIONS OR CONTACT DANIEL SADEH OR ZACHARY HALPER AT (212) 763-0060 OR SADEH@HALPERSADEH.COM OR ZHALPER@HALPERSADEH.COM. THE INVESTIGATION CONCERNS WHETHER ZIX AND ITS BOA
|
ZIXI MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF ZIX CORPORATION IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – ZIXI
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-08 08:37:00
| null |
DALLAS--(BUSINESS WIRE)--ZIX CORPORATION (ZIX) (NASDAQ: ZIXI), A LEADING PROVIDER OF CLOUD EMAIL SECURITY, PRODUCTIVITY, AND COMPLIANCE SOLUTIONS, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021. THIRD QUARTER 2021 FINANCIAL HIGHLIGHTS (RESULTS COMPARED TO THE SAME YEAR-AGO QUARTER) REVENUE INCREASED 18% TO $64.9 MILLION. ANNUAL RECURRING REVENUE (ARR) INCREASED 18% TO $262.8 MILLION. CLOUD ARR INCREASED 19% TO $236.9 MILLION OR 90% OF TOTAL ARR. GAAP NET LOSS T
|
ZIX REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-08 08:35:00
| null |
DALLAS--(BUSINESS WIRE)--ZIX CORPORATION (NASDAQ: ZIXI) (“ZIX”), A LEADING PROVIDER OF CLOUD EMAIL SECURITY, THREAT PROTECTION AND COMPLIANCE CLOUD SOLUTIONS FOR SMALL AND MEDIUM-SIZED BUSINESSES (SMBS), TODAY ANNOUNCED THAT IT HAS ENTERED INTO A DEFINITIVE AGREEMENT TO BE ACQUIRED BY OPENTEXT™, A MARKET-LEADING PROVIDER OF INFORMATION MANAGEMENT SOLUTIONS, FOR $8.50 PER SHARE IN CASH, REPRESENTING AN ENTERPRISE VALUE OF $860 MILLION. “WE ARE PLEASED TO ANNOUNCE THIS TRANSACTION WITH OPENTEXT,”
|
ZIX TO BE ACQUIRED BY OPENTEXT™ FOR $8.50 PER SHARE IN CASH
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-12 11:38:00
| null |
DALLAS--(BUSINESS WIRE)--ZIX CORPORATION (ZIX) (NASDAQ: ZIXI), A LEADING PROVIDER OF CLOUD EMAIL SECURITY, PRODUCTIVITY, AND COMPLIANCE SOLUTIONS, TODAY ANNOUNCED ITS CLOUD-BASED DATA BACKUP AND RECOVERY SOLUTION IS NOW AVAILABLE THROUGH ITS INTUITIVE SECURE CLOUD PLATFORM. NOW, CUSTOMERS CAN EXPERIENCE COMPLETE VISIBILITY INTO COMMUNICATION SECURITY AND COMPLIANCE FOR MICROSOFT OFFICE 365, GOOGLE WORKSPACE, SHAREPOINT, ONEDRIVE, SALESFORCE, BOX AND DROPBOX. ZIX IS COMMITTED TO PROVIDING COMPRE
|
ZIX ANNOUNCES CLOUD BACKUP AND RECOVERY SERVICES NOW AVAILABLE THROUGH SECURE CLOUD
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-21 08:00:00
| null |
DALLAS--(BUSINESS WIRE)--ZIX DELIVERS SECURE LARGE FILE ADD-ON TO IMPROVE COLLABORATION BY ALLOWING ANY AUTHORIZED USER TO SEND LARGE ATTACHMENTS VIA EMAIL
|
ZIX DELIVERS SECURE LARGE FILE SHARE TO BOLSTER INNOVATION FOR EMAIL ENCRYPTION SERVICES
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-04 16:05:00
| null |
DALLAS--(BUSINESS WIRE)--ZIX CORPORATION (ZIX) (NASDAQ: ZIXI), A LEADER IN EMAIL SECURITY, WILL HOLD ITS 2021 ANNUAL SHAREHOLDERS MEETING AT 10 A.M. CT ON WEDNESDAY, JUNE 9, 2021. THE EVENT WILL BE A VIRTUAL MEETING HELD OVER THE INTERNET. YOU WILL BE ABLE TO ATTEND BY ACCESSING THE FOLLOWING LINK: WWW.VIRTUALSHAREHOLDERMEETING.COM/ZIXI2021. THE MEETING WILL INCLUDE BRIEF REMARKS FROM CHIEF EXECUTIVE OFFICER DAVID WAGNER ON THE COMPANY'S OUTLOOK AND RECENT FINANCIAL AND OPERATIONAL ACHIEVEMENTS
|
ZIX TO HOLD 2021 ANNUAL SHAREHOLDERS MEETING ON WEDNESDAY, JUNE 9, 2021
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-26 04:00:00
| null |
DALLAS--(BUSINESS WIRE)--ZIX CORPORATION (ZIX), (NASDAQ: ZIXI), A LEADING PROVIDER OF CLOUD EMAIL SECURITY, PRODUCTIVITY, AND COMPLIANCE SOLUTIONS, TODAY ANNOUNCED THE EXPANSION OF ITS GLOBAL PARTNER PROGRAM IN GERMANY AND THE UNITED KINGDOM (UK). ZIX GERMAN PARTNERS WILL NOW BE ABLE TO TAKE ADVANTAGE OF LOCALIZED PRODUCT OFFERINGS, INCLUDING ADVANCED THREAT PROTECTION, SECURE FILE SHARE AND A DEDICATED PARTNER PORTAL. IN THE UK, EXISTING AND NEW PARTNERS, BE ABLE TO ADD DATA ARCHIVE RESIDENCY
|
ZIX EXPANDS GLOBAL PARTNER PROGRAM IN THE UNITED KINGDOM AND GERMANY
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-05 18:30:00
| null |
ZIX REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS.Q2 GAAP LOSS PER SHARE $0.08.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.15.SEES Q3 2020 REVENUE $53.5 MILLION TO $54 MILLION.Q2 REVENUE $53.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $52.4 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.14 -- REFINITIV IBES DATA.Q3 EARNINGS PER SHARE VIEW $0.15, REVENUE VIEW $53.6 MILLION -- REFINITIV IBES DATA.SEES 2020 REVENUE TO RANGE BETWEEN $211 MILLION AND $217 MILLION.SEES 2020 FULLY DILUTED GAAP LOSS PER SHARE TO RANGE BETWEEN $0.13 AND $0.09.ZIX - NON-GAAP ADJUSTED EARNINGS PER SHARE BEFORE DEEMED DIVIDENDS AND EXCLUDING DEFERRED TAX (BENEFIT) EXPENSE TO BE $0.58 TO $0.60 FOR 2020.FY2020 EARNINGS PER SHARE VIEW $0.57, REVENUE VIEW $213.2 MILLION -- REFINITIV IBES DATA.
|
ZIX REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-20 21:30:00
| null |
SEES FY 2020 LOSS PER SHARE BETWEEN $0.10 AND $0.07 .SEES Q1 2020 ADJUSTED. EARNINGS PER SHARE $0.12 - $0.14 .SEES FY 2020 ADJUSTED EARNINGS PER SHARE $0.57 TO $0.60.ZIX REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS.Q4 GAAP LOSS PER SHARE $0.10.SEES FY 2020 REVENUE $220 MILLION TO $225 MILLION.Q4 REVENUE $50.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $49.6 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.14 -- REFINITIV IBES DATA.SEES Q1 2020 REVENUE $52.2 MILLION TO $52.7 MILLION.Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.13.SEES Q1 2020 LOSS PER SHARE $0.04 - $0.03.FORECASTS ADJUSTED EBITDA TO BE APPROXIMATELY 23% OF FORECAST REVENUE FOR Q1 2020.PER SHARE GUIDANCE FIGURES ARE BASED ON AN APPROXIMATE BASIC SHARE COUNT OF 53.3 MILLION FOR Q1 2020.EXPECTS ARR AT END OF FISCAL 2020 TO BE IN RANGE OF $243 MILLION TO $247 MILLION.Q1 EARNINGS PER SHARE VIEW $0.13 -- REFINITIV IBES DATA.
|
ZIX Q4 GAAP LOSS PER SHARE $0.10
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-06 22:30:00
| null |
ZIX CORPORATION PRESENTS AT THE 10TH ANNUAL CRAIG-HALLUM ALPHA SELECT CONFERENCE, NOV-12-2019 . VENUE: SHERATON NEW YORK TIMES SQUARE HOTEL, 811 SEVENTH AVENUE, NEW YORK, NEW YORK, UNITED STATES. SPEAKERS: DAVE ROCKVAM, CHIEF FINANCIAL OFFICER, DAVE WAGNER, CHIEF EXECUTIVE OFFICER.
|
ZIX CORPORATION PRESENTS AT THE 10TH ANNUAL CRAIG-HALLUM ALPHA SELECT CONFERENCE, NOV-12-2019
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-31 09:30:00
| null |
ZIX REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 GAAP LOSS PER SHARE $0.07.SEES Q4 2019 REVENUE $49 MILLION TO $50 MILLION.Q3 REVENUE $47.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $47.3 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.13 -- REFINITIV IBES DATA.SEES Q4 2019 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.14.SEES Q4 2019 GAAP LOSS PER SHARE $0.02 TO $0.03.Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $13.00.FOR FULL FISCAL YEAR OF 2019, CO IS INCREASING ITS PREVIOUSLY DISCLOSED REVENUE GUIDANCE TO A RANGE OF BETWEEN $172.0 MILLION TO $173.0 MILLION.COMPANY ALSO UPDATES ITS 2019 FULLY DILUTED GAAP EARNINGS GUIDANCE TO A RANGE OF BETWEEN LOSS PER SHARE OF $0.25 AND $0.23.FULLY DILUTED NON-GAAP ADJUSTED EARNINGS PER SHARE GUIDANCE TO BE $0.44 TO $0.45 FOR FISCAL YEAR 2019.
|
ZIX REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-30 22:30:00
| null |
ZIX CORPORATION PROVIDED EARNINGS GUIDANCE FOR THE FOURTH QUARTER AND REVISED EARNINGS GUIDANCE FOR THE FULL YEAR OF 2019. FOR THE FOURTH QUARTER OF 2019, THE COMPANY FORECASTS REVENUE TO RANGE BETWEEN $49.0 MILLION AND $50.0 MILLION. THE COMPANY FORECASTS FULLY DILUTED GAAP LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS TO BE IN A RANGE OF $0.03 AND $0.02.FOR THE FULL FISCAL YEAR OF 2019, THE COMPANY IS INCREASING ITS PREVIOUSLY DISCLOSED REVENUE GUIDANCE TO A RANGE OF BETWEEN $172.0 MILLION TO $173.0 MILLION (PREVIOUSLY $170.0 MILLION TO $172.0 MILLION), REPRESENTING AN INCREASE OF BETWEEN 144% AND 145% (PREVIOUSLY 141% AND 144%) COMPARED TO FISCAL YEAR 2018. THE COMPANY ALSO UPDATES ITS FULLY DILUTED GAAP EARNINGS LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS GUIDANCE TO A RANGE OF BETWEEN $0.25 AND $0.23 (PREVIOUSLY $0.24 AND $0.21).
|
ZIX CORPORATION PROVIDES EARNINGS GUIDANCE FOR THE FOURTH QUARTER AND REVISES EARNINGS GUIDANCE FOR THE FULL YEAR OF 2019
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-24 22:30:00
| null |
ZIX CORPORATION PRESENTS AT 2019 SOUTHWEST IDEAS INVESTOR CONFERENCE, NOV-20-2019 07:20 AM. VENUE: WESTIN DALLAS DOWNTOWN, 1201 MAIN STREET, DALLAS, TEXAS, UNITED STATES.
|
ZIX CORPORATION PRESENTS AT 2019 SOUTHWEST IDEAS INVESTOR CONFERENCE, NOV-20-2019 07:20 AM
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-23 22:30:00
| null |
ZIX CORPORATION PRESENTS AT NEEDHAM SECURITY, NETWORKING AND COMMUNICATIONS CONFERENCE, NOV-12-2019 10:40 AM. VENUE: NEW YORK, NEW YORK, UNITED STATES. SPEAKERS: DAVE ROCKVAM, CHIEF FINANCIAL OFFICER, DAVE WAGNER, CHIEF EXECUTIVE OFFICER.
|
ZIX CORPORATION PRESENTS AT NEEDHAM SECURITY, NETWORKING AND COMMUNICATIONS CONFERENCE, NOV-12-2019 10:40 AM
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-06 22:30:00
| null |
ZIX CORPORATION, Q3 2019 EARNINGS CALL, OCT 31, 2019
|
ZIX CORPORATION, Q3 2019 EARNINGS CALL, OCT 31, 2019
|
ZIXI
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-10-19 17:00:00
| null |
WENZHOU, CHINA , OCT. 19, 2022 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY") TODAY ANNOUNCED THAT THE COMPANY RECEIVED A NOTICE FROM THE NASDAQ STOCK MARKET LLC ("NASDAQ"), DATED OCT. 13, 2022, NOTIFYING THE COMPANY THAT IT IS CURRENTLY NOT IN COMPLIANCE WITH THE MINIMUM BID PRICE REQUIREMENT SET FORTH UNDER NASDAQ LISTING RULE 5450(A)(1) (THE "RULE") BECAUSE THE BID PRICE OF THE COMPANY'S ORDINARY SHARES FAIL TO MAINTAIN A MINIMUM BID PRICE OF US$1.00 PER SHARE FOR THE LAST 30 CONSECUTIVE BUSINESS DAYS FROM AUGUST 31, 2022 TO OCTOBER 12, 2022.
|
ZK INTERNATIONAL RECEIVES NASDAQ NOTICE REGARDING MINIMUM BID REQUIREMENTS
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-10-05 09:00:00
| null |
MAXIMBET'S ENTRY INTO THE HOOSIER STATE DEBUTS NEW BEST-IN-CLASS TECHNOLOGY, MICROBETTING, INNOVATIVE PROMOS AND MORE WENZHOU, CHINA , OCT. 5, 2022 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. ( NASDAQ: ZKIN ) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT ITS PORTFOLIO COMPANY, MAXIMBET , THE LIFESTYLE SPORTS BETTING AND ONLINE CASINO BRAND OWNED AND OPERATED BY CAROUSEL GROUP AND IN PARTNERSHIP WITH MAXIM, ANNOUNCED THAT IT CONTINUES ITS RAPID NORTH AMERICAN EXPANSION WITH THE LAUNCH OF ITS SPORTSBOOK IN INDIANA, THE SECOND LIVE U.S. STATE FOR THE EMERGING SPORTS BETTING BRAND.
|
ZK INTERNATIONAL'S PORTFOLIO COMPANY MAXIMBET CONTINUES ITS MULTI-STATE EXPANSION BY LAUNCHING IN INDIANA
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-07-18 09:00:00
| null |
WENZHOU, CHINA , JULY 18, 2022 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT AS PART OF ITS PROCUREMENT SUCCESS, THE COMPANY HAS STARTED TO SUPPLY THE THIN-WALL STAINLESS STEEL PIPE TO FUZHOU WATER SUPPLY CHAIN MANAGEMENT CO., LTD, WHICH HAS ONE OF THE LARGEST WATER SUPPLY CHAINS IN CHINA.
|
ZK INTERNATIONAL RANKS THE FIRST IN A $5 MILLION BID TO SUPPLY THIN-WALLED STAINLESS STEEL PIPES TO THE FUZHOU WATER PROCUREMENT PROJECT
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-26 13:25:00
| null |
WENZHOU, CHINA, JAN. 26, 2022 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT ITS PORTFOLIO COMPANY, MAXIMBET, THE LIFESTYLE SPORTS BETTING AND ONLINE CASINO BRAND OWNED AND OPERATED BY CAROUSEL GROUP AND IN PARTNERSHIP WITH MAXIM, TODAY ANNOUNCED EXCLUSIVE MULTI-YEAR AGREEMENTS WITH TWO OF THE PREEMINENT NAMES IN BETTING AND GAMING AS IT CONTINUES ITS RAPID NORTH AMERICAN EXPANSION.
|
ZK INTERNATIONAL'S PORTFOLIO COMPANY, MAXIMBET, ENTERS INTO EXCLUSIVE MULTI-YEAR AGREEMENTS WITH KAMBI GROUP AND WHITE HAT GAMING
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-13 08:45:00
| null |
WENZHOU, CHINA, JAN. 13, 2022 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT ZK INTERNATIONAL HAS COMPLETED THE YEAR ON A HIGH NOTE BY BEING ABLE TO WIN PROJECT BIDDING AND BRING CONTRACTS WITH TOTAL CONTRACT SALES AMOUNT OF $5 MILLION DURING THE MONTH OF DECEMBER 2021.
|
ZK INTERNATIONAL ANNOUNCES NEW CONTRACTS WITH TOTAL CONTRACT AMOUNT OF USD $5 MILLION IN THE LAST MONTH OF 2021
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-22 09:00:00
| null |
WENZHOU, CHINA, NOV. 22, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD'S (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), AND ITS SUBSIDIARY XSIGMA COLLECTIBLES ("XSIGMA"), ARE PLEASED TO ANNOUNCE THAT MAXIMNFT, AN NFT MARKETPLACE LAUNCHED BY XSIGMA IN EXCLUSIVE PARTNERSHIP WITH MAXIM MAGAZINE, WILL PUBLICLY LAUNCH ITS BETA ON NOVEMBER 29 TH. A HOST OF SPORTS SUPERSTARS, INCLUDING MATT CARPENTER, JERAMI GRANT, AND QUINTON "RAMPAGE" JACKSON, WILL LAUNCH THEIR EXCLUSIVE NFT COLLECTIONS ON THE PLATFORM.
|
MAXIM NFT LAUNCHES ITS NFT MARKETPLACE THIS MONTH WITH COLLECTIONS FROM SPORTS STARS MATT CARPENTER, JERAMI GRANT, AND RAMPAGE JACKSON
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-02 09:00:00
| null |
WENZHOU, CHINA, NOV. 2, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD'S (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), AND ITS SUBSIDIARY XSIGMA COLLECTIBLES ("XSIGMA"), IS EXCITED TO ANNOUNCE THAT THREE NFL PLAYERS WILL SOON LAUNCH UNIQUE NFT COLLECTIONS RESPECTIVELY WITH MAXIMNFT. THESE PROFESSIONAL ATHLETES INCLUDE JANORIS JENKINS, DEVON KENNARD, AND DENZEL PERRYMAN.
|
NFL FOOTBALL PLAYERS, JANORIS JENKINS, DEVON KENNARD AND DENZEL PERRYMAN, TO LAUNCH NFT COLLECTIONS ON MAXIMNFT
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-13 09:00:00
| null |
WENZHOU, CHINA, OCT. 13, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD'S (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), AND ITS SUBSIDIARY XSIGMA COLLECTIBLES ("XSIGMA"), IS PLEASED TO ANNOUNCE THAT BRIAN TRACY, AUTHOR OF THE BESTSELLING BOOK "THE PSYCHOLOGY OF ACHIEVEMENT", WILL LAUNCH A CHARITABLE NFT COLLECTION ON MAXIMNFT. MAXIMNFT IS AN UPCOMING NFT MARKETPLACE LAUNCHED BY XSIGMA IN EXCLUSIVE PARTNERSHIP WITH MAXIM MAGAZINE.
|
ZK INTERNATIONAL'S SUBSIDIARY'S PROJECT, MAXIMNFT, WILL HOST BESTSELLING AUTHOR BRIAN TRACEY'S CHARITABLE NFT COLLECTION
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-07 09:00:00
| null |
WENZHOU, CHINA, OCT. 7, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD'S (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), AND ITS SUBSIDIARY XSIGMA COLLECTIBLES, IS PLEASED TO ANNOUNCE THAT CRIS CYBORG, A CURRENT BELLATOR AND FORMER UFC CHAMPION, WILL LAUNCH A UNIQUE NFT COLLECTION ON MAXIMNFT. MAXIMNFT IS AN UPCOMING NFT MARKETPLACE LAUNCHED BY XSIGMA IN EXCLUSIVE PARTNERSHIP WITH MAXIM MAGAZINE.
|
ZK INTERNATIONAL'S SUBSIDIARY'S PROJECT, MAXIMNFT, WILL HOST CRIS CYBORG'S OFFICIAL NFT COLLECTION AND WILL BE PROMOTED ON BELLATOR 271 FIGHT
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-23 08:30:00
| null |
WENZHOU, CHINA, SEPT. 23, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD'S (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT, XSIGMA COLLECTIBLES LIMITED (THE "XSIGMA"), A SUBSIDIARY OF THE COMPANY, HAS ENTERED INTO A GENERAL PARTNERSHIP WITH ACES, INC., A LEADING US BASEBALL AGENCY, TO LAUNCH NFTS FOR THEIR ATHLETES ON THE MAXIMNFT PLATFORM.
|
ZK INTERNATIONAL THROUGH ITS OWNERSHIP IN MAXIMNFT, PARTNERS WITH ACES, A FORBES LIST OF THE WORLD'S MOST POWERFUL SPORTS AGENTS, LAUNCHES NFTS FOR ITS ATHLETES
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-20 08:30:00
| null |
WENZHOU, CHINA, SEPT. 20, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD.
|
MAXIMBET LAUNCHES IN COLORADO TO BIG OPENING WEEKEND, ANNOUNCES FIRST-EVER HALLOWEEN PARTY FOR SPORTS FANS
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-15 08:30:00
| null |
WENZHOU, CHINA, SEPT. 15, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD.
|
ZK INTERNATIONAL INVESTS AN ADDITIONAL $10 MILLION IN MAXIMBET
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-08 09:30:00
| null |
WENZHOU, CHINA, SEPT. 8, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD.
|
ZK INTERNATIONAL'S SUBSIDIARY, XSIGMA, APPOINTS JON ORLANDO AS CEO OF MAXIMNFT, GETTING READY TO LAUNCH ITS NFT MARKETPLACE TOGETHER WITH MAXIM.COM
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-07 08:30:00
| null |
WENZHOU, CHINA, SEPT. 7, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD.
|
ZK INTERNATIONAL STARTS TO SUPPLY TO ONE OF CHINA'S LARGEST DISTRIBUTORS OF GAS, ENN ENERGY, WITH AN ESTIMATED TOTAL SALES AMOUNT OF USD $12.5 MILLION
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-26 09:15:00
| null |
WENZHOU, CHINA, AUG. 26, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY") HAS FORMED A WHOLLY OWNED SUBSIDIARY, XSIGMA COLLECTIBLES LIMITED ("XSIGMA"), AND ENTERED INTO A PARTNERSHIP AGREEMENT WITH MAXIM (HTTPS://WWW.MAXIM.COM) TO LAUNCH MAXIMNFT.COM, THE EXCLUSIVE NFT (NON-FUNGIBLE TOKEN) MARKETPLACE OF THE ICONIC MEN'S LIFESTYLE BRAND.
|
ZK INTERNATIONAL'S BLOCKCHAIN INNOVATION HUB, XSIGMA, LAUNCHES MAXIMNFT.COM, AN EXCLUSIVE NFT MARKETPLACE IN PARTNERSHIP WITH MAXIM
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-12 09:00:00
| null |
WENZHOU, CHINA, AUG. 12, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT ITS PORTFOLIO COMPANY, MAXIMBET, THE EMERGING ONLINE SPORTS BETTING LIFESTYLE BRAND, TODAY ANNOUNCED PLANS TO PARTNER WITH THE WHITE MOUNTAIN APACHE TRIBE IN THE RECENTLY LEGALIZED ARIZONA SPORTS BETTING MARKET.
|
ZK INTERNATIONAL'S PORTFOLIO COMPANY, MAXIMBET, ENTERS PARTNERSHIP WITH WHITE MOUNTAIN APACHE TRIBE IN PURSUIT OF ONLINE SPORTS BETTING LICENSE IN ARIZONA
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-21 09:00:00
| null |
WENZHOU, CHINA , JULY 21, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT XSIGMA CORPORATION, A SUBSIDIARY OF THE COMPANY AND A BLOCKCHAIN R&D LAB, HAS COMPLETED THE SMART CONTRACT DEVELOPMENT FOR ITS NFT ("NON-FUNGIBLE TOKEN") MARKETPLACE AND SUCCESSFULLY PASSED A SMART CONTRACT AUDIT BY HASHEX.
|
ZK INTERNATIONAL'S SUBSIDIARY, XSIGMA, SUCCESSFULLY COMPLETES AN AUDIT OF ITS NFT MARKETPLACE AHEAD OF ITS LAUNCH, WHILE WORKING ON STRATEGIC PARTNERSHIPS
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-21 09:30:00
| null |
WENZHOU, CHINA, JUNE 21, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT THE COMPANY PLANS TO EXPAND ITS SALES NETWORK AND OPERATIONS INTO EUROPE AND NORTH AMERICA.
|
ZK INTERNATIONAL LOOKS TO SUPPLY INTERNATIONAL MARKETS THAT FACE SHORTAGES IN CONSTRUCTION MATERIALS
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-18 09:00:00
| null |
WENZHOU, CHINA, MAY 18, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT THE COMPANY HAS WON THE STRONGLY CONTESTED PRESSED-TYPE CARBON STEEL PIPE PROCUREMENT CONTRACT WITH ENN ENERGY HOLDINGS LIMITED ("ENN"), WHICH IS ONE OF THE LARGEST CLEAN ENERGY DISTRIBUTORS IN CHINA.
|
ZK INTERNATIONAL WINS BID WITH ONE OF CHINA'S LARGEST SUPPLIERS OF GAS, ENN ENERGY
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-29 12:40:00
| null |
WENZHOU, CHINA, APRIL 29, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD . (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL") IS PLEASED TO ANNOUNCE THAT THERE IS NOW OPTIONS TRADING AVAILABLE ON THE COMPANY.
|
ZK INTERNATIONAL ANNOUNCES OPTION TRADING NOW AVAILABLE FOR THE COMPANY
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-21 11:34:00
| null |
WENZHOU, CHINA, APRIL 21, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL") IS PLEASED TO ANNOUNCE THAT XSIGMA ENTERTAINMENT, A WHOLLY-OWNED SUBSIDIARY OF ZK INTERNATIONAL, ANNOUNCED THE ACQUISITION OF A LIVE GOLF BETTING SOFTWARE.
|
ZK INTERNATIONAL'S WHOLLY OWNED SUBSIDIARY, XSIGMA ENTERTAINMANENT ANNOUNCES THE ACQUISITION OF A LIVE GOLF BETTING SOFTWARE
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-05 10:45:00
| null |
WENZHOU, CHINA, APRIL 5, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE SUSAN KILKENNY HAS JOINED THE COMPANY AS A SENIOR STRATEGIC MARKETING ADVISOR TO XSIGMA ENTERTAINMENT LIMITED, A WHOLLY-OWNED SUBSIDIARY OF ZK INTERNATIONAL GROUP CO., LTD.
|
ZK INTERNATIONAL ADDS AWARD-WINNING SALES & MARKETING STRATEGIST, SUSAN KILKENNY, AS ITS SENIOR STRATEGIC MARKETING ADVISOR
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-30 11:26:00
| null |
NEW YORK, MARCH 30, 2021 /PRNEWSWIRE/ -- ORTOLI ROSENSTADT LLP, A NEW YORK FULL-SERVICE INTERNATIONAL LAW FIRM, TODAY ANNOUNCED THAT IT REPRESENTED ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN), A MANUFACTURER AND SUPPLIER OF PATENTED HIGH-PERFORMANCE STAINLESS STEEL AND CARBON STEEL PIPE PRODUCTS, IN A REGISTERED DIRECT OFFERING WITH A GROUP OF INVESTORS.
|
ORTOLI ROSENSTADT LLP REPRESENTS ZK INTERNATIONAL GROUP CO., LTD. IN $18 MILLION REGISTERED DIRECT OFFERING
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-24 08:30:00
| null |
WENZHOU, CHINA, MARCH 24, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT THE COMPANY HAS FORMED A NEW WHOLLY-OWNED SUBSIDIARY, XSIGMA ENTERTAINMENT LIMITED, WITH THE INTENT OF ACQUIRING ONLINE GAMING ASSETS.
|
ZK INTERNATIONAL FORMS XSIGMA ENTERTAINMENT WITH THE INTENTION OF ACQUIRING ONLINE GAMING ASSETS
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-23 13:57:00
| null |
WENZHOU, CHINA, MARCH 23, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), A DESIGNER, ENGINEER, MANUFACTURER, AND SUPPLIER OF PATENTED HIGH-PERFORMANCE STAINLESS STEEL AND CARBON STEEL PIPE PRODUCTS THAT REQUIRE SOPHISTICATED WATER OR GAS PIPELINE SYSTEMS, TODAY ANNOUNCED THAT THE COMPANY HAS BEEN CHOSEN AS A KEY SUPPLIER FOR GUANGYUAN MUNICIPAL NATURAL GAS SUPPLY INFRASTRUCTURE PROGRAM AND ENTERED INTO A TWO-YEAR STRATEGIC PROCUREMENT AGREEMENT WITH GUANGYUAN NATURAL GAS SUPPLY GROUP CO., LTD.
|
ZK INTERNATIONAL EXPANDS ITS MARKET TO WESTERN CHINA AS IT WINS A TWO YEAR PROCUREMENT BID TO SUPPLY FOR THE MUNICIPAL GAS INFRASTRUCTURE WITH GUANGYUAN NATURAL GAS SUPPLY GROUP
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-18 08:30:00
| null |
WENZHOU, CHINA, FEB. 18, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT XSIGMA CORPORATION, A SUBSIDIARY OF THE COMPANY AND A BLOCKCHAIN R&D LAB, IS ANNOUNCING THAT THE SMART CONTRACTS OF ITS...
|
ZK INTERNATIONAL'S SUBSIDIARY, XSIGMA CORPORATION, ANNOUNCING THE SUCCESSFUL COMPLETION OF ITS DEFI PROTOCOL AUDIT
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-12 16:30:00
| null |
WENZHOU, CHINA, JAN. 12, 2021 /PRNEWSWIRE/ -- ZK INTERNATIONAL GROUP CO., LTD. (NASDAQ: ZKIN) ("ZKIN", "ZK INTERNATIONAL" OR THE "COMPANY"), A DESIGNER, ENGINEER, MANUFACTURER, AND SUPPLIER OF PATENTED HIGH-PERFORMANCE STAINLESS STEEL AND CARBON STEEL PIPE PRODUCTS PRIMARILY USED FOR...
|
ZK INTERNATIONAL SUBSIDIARY, XSIGMA CORPORATION, RELEASES THE WHITEPAPER FOR ITS DEFI PROTOCOL
|
ZKIN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.